BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brock C, Olesen SS, Olesen AE, Frøkjaer JB, Andresen T, Drewes AM. Opioid-induced bowel dysfunction: pathophysiology and management. Drugs. 2012;72:1847-1865. [PMID: 22950533 DOI: 10.2165/11634970-000000000-00000] [Cited by in Crossref: 131] [Cited by in F6Publishing: 122] [Article Influence: 13.1] [Reference Citation Analysis]
Number Citing Articles
1 Jalodia R, Abu YF, Oppenheimer MR, Herlihy B, Meng J, Chupikova I, Tao J, Ghosh N, Dutta RK, Kolli U, Yan Y, Valdes E, Sharma M, Sharma U, Moidunny S, Roy S. Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System. J Neuroimmune Pharmacol 2022. [PMID: 34993905 DOI: 10.1007/s11481-021-10046-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ostan R, Gambino G, Malavasi I, Ronga G, Solipaca M, Spunghi M, Varani S, Pannuti R, Ruggeri E. Can Naloxegol Therapy Improve Quality of Life in Patients with Advanced Cancer? Cancers (Basel) 2021;13:5736. [PMID: 34830889 DOI: 10.3390/cancers13225736] [Reference Citation Analysis]
3 Olesen SS, Phillips AE, Faghih M, Kuhlmann L, Steinkohl E, Frøkjær JB, Bick BL, Ramsey ML, Hart PA, Garg PK, Singh VK, Yadav D, Drewes AM; Pancreatic Quantitative Sensory Testing (P-QST) Consortium. Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing and psychological distress on patient-reported outcomes in chronic pancreatitis. Gut 2021:gutjnl-2021-325855. [PMID: 34675068 DOI: 10.1136/gutjnl-2021-325855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hill R, Canals M. Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology. Pharmacol Ther 2021;:107961. [PMID: 34256067 DOI: 10.1016/j.pharmthera.2021.107961] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 De Giorgio R, Zucco FM, Chiarioni G, Mercadante S, Corazziari ES, Caraceni A, Odetti P, Giusti R, Marinangeli F, Pinto C. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Adv Ther 2021;38:3589-621. [PMID: 34086265 DOI: 10.1007/s12325-021-01766-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Törnblom H, Drossman DA. Psychopharmacologic Therapies for Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:655-69. [PMID: 34304793 DOI: 10.1016/j.gtc.2021.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen Z, Zhijie C, Yuting Z, Chan L, Shilin X, Qichun Z, Jinying O, Jing L, Chaohua L, Zhixian M. The Ameliorative Effects of Isorhynchophylline on Morphine Dependence Are Mediated Through the Microbiota-Gut-Brain Axis. Front Pharmacol 2021;12:526923. [PMID: 34168553 DOI: 10.3389/fphar.2021.526923] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wachtendorf LJ, Schaefer MS, Santer P, Azimaraghi O, Obeidat SS, Friedrich S, Zucco L, Woo A, Nabel S, Sundar E, Eikermann M, Ramachandran SK. Association between preoperative administration of gabapentinoids and 30-day hospital readmission: A retrospective hospital registry study. J Clin Anesth 2021;73:110376. [PMID: 34098392 DOI: 10.1016/j.jclinane.2021.110376] [Reference Citation Analysis]
9 Mark EB, Nedergaard RB, Hansen TM, Nissen TD, Frøkjaer JB, Scott SM, Krogh K, Drewes AM. Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers. Neurogastroenterol Motil 2021;:e14131. [PMID: 34051122 DOI: 10.1111/nmo.14131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mishra S, Singh R, Satapathy S, Bhatnagar S. Validity and Reliability of the Hindi Version of the Patient Assessment of Constipation Quality of Life Questionnaire in Cancer Patients on Opioids for Pain Management at Tertiary Care Center, India. Indian J Palliat Care 2021;27:95-8. [PMID: 34035624 DOI: 10.4103/IJPC.IJPC_187_20] [Reference Citation Analysis]
11 Schneider A, Hirth M. Pain Management in Chronic Pancreatitis: Summary of Clinical Practice, Current Challenges and Potential Contribution of the M-ANNHEIM Classification. Drugs 2021;81:533-46. [PMID: 33587287 DOI: 10.1007/s40265-021-01472-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Sarrió RG, Calsina-Berna A, García AG, Esparza-Miñana JM, Ferrer EF, Porta-Sales J; Working Group ActEIO Project. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. BMC Palliat Care 2021;20:1. [PMID: 33388041 DOI: 10.1186/s12904-020-00693-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Piekielna-Ciesielska J, Artali R, Azzam AAH, Lambert DG, Kluczyk A, Gentilucci L, Janecka A. Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation. Molecules 2020;26:E13. [PMID: 33375124 DOI: 10.3390/molecules26010013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hanafi AL, Reed RA, Trenholme HN, Sakai DM, Ryan CA, Barletta M, Quandt JE, Knych HK. Pharmacokinetics and pharmacodynamics of meperidine after intramuscular and subcutaneous administration in horses. Vet Surg 2021;50:410-7. [PMID: 33242227 DOI: 10.1111/vsu.13545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Geeraerts A, Geysen H, Ballet L, Hofmans C, Clevers E, Omari T, Manolakis AC, Mols R, Augustijns P, Vanuytsel T, Rommel N, Tack J, Pauwels A. Codeine induces increased resistance at the esophagogastric junction but has no effect on motility and bolus flow in the pharynx and upper esophageal sphincter in healthy volunteers: A randomized, double-blind, placebo-controlled, cross-over trial. Neurogastroenterol Motil 2021;33:e14041. [PMID: 33232555 DOI: 10.1111/nmo.14041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Faghih M, Phillips AE, Kuhlmann LF, Afghani E, Drewes AM, Yadav D, Singh VK, Olesen SS; Pancreatic Quantitative Sensory Testing (P-QST) Consortium. Pancreatic QST Differentiates Chronic Pancreatitis Patients into Distinct Pain Phenotypes Independent of Psychiatric Comorbidities. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31494-4. [PMID: 34108130 DOI: 10.1016/j.cgh.2020.10.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Seilhamer C, Di Lorenzo C, Holstine J, Samora JB. Creating a bowel management plan for pediatric orthopaedic spine surgery patients. Spine Deform 2021;9:365-71. [PMID: 32978749 DOI: 10.1007/s43390-020-00212-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Micheli L, Di Cesare Mannelli L, Lucarini E, Parisio C, Toti A, Fiorentino B, Rigamonti MA, Calosi L, Ghelardini C. Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study. Front Pharmacol 2020;11:576624. [PMID: 33071790 DOI: 10.3389/fphar.2020.576624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sarkar A, Adamska-Bartlomiejczyk A, Piekielna-Ciesielska J, Wtorek K, Kluczyk A, Borics A, Janecka A. Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore. Molecules 2020;25:E4260. [PMID: 32957550 DOI: 10.3390/molecules25184260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Skrzypczak H, Reed R, Barletta M, Quandt J, Sakai D. A retrospective evaluation of the effect of perianesthetic hydromorphone administration on the incidence of postanesthetic signs of colic in horses. Vet Anaesth Analg 2020;47:757-62. [PMID: 32830037 DOI: 10.1016/j.vaa.2020.06.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Vekariya RH, Lei W, Ray A, Saini SK, Zhang S, Molnar G, Barlow D, Karlage KL, Bilsky EJ, Houseknecht KL, Largent-milnes TM, Streicher JM, Ananthan S. Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects. J Med Chem 2020;63:7663-94. [DOI: 10.1021/acs.jmedchem.0c00503] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wtorek K, Piekielna-Ciesielska J, Janecki T, Janecka A. The search for opioid analgesics with limited tolerance liability. Peptides 2020;130:170331. [PMID: 32497566 DOI: 10.1016/j.peptides.2020.170331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
23 Piekielna-Ciesielska J, Wtorek K, Janecka A. Biased Agonism as an Emerging Strategy in the Search for Better Opioid Analgesics. Curr Med Chem 2020;27:1562-75. [PMID: 31057099 DOI: 10.2174/0929867326666190506103124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Daniali M, Nikfar S, Abdollahi M. Evaluating naloxegol for the treatment of opioid-induced constipation. Expert Opinion on Pharmacotherapy 2020;21:883-91. [DOI: 10.1080/14656566.2020.1735354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
26 Mesía R, Virizuela Echaburu JA, Gómez J, Sauri T, Serrano G, Pujol E. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management. Curr Treat Options Oncol 2019;20:91. [PMID: 31853656 DOI: 10.1007/s11864-019-0686-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
27 Long DD, Armstrong SR, Beattie DT, Campbell CB, Church TJ, Colson PJ, Dalziel SM, Jacobsen JR, Jiang L, Obedencio GP, Rapta M, Saito D, Stergiades I, Tsuruda PR, Van Dyke PM, Vickery RG. Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor Antagonist. ACS Med Chem Lett 2019;10:1641-7. [PMID: 31857840 DOI: 10.1021/acsmedchemlett.9b00406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Salle S, Bodeau S, Dhersin A, Ferdonnet M, Goncalves R, Lenski M, Lima B, Martin M, Outreville J, Vaucel J, Fabresse N. Novel synthetic opioids: A review of the literature. Toxicologie Analytique et Clinique 2019;31:298-316. [DOI: 10.1016/j.toxac.2019.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Mark EB, Klinge MW, Grønlund D, Poulsen JL, Schlageter V, Scott SM, Krogh K, Drewes AM. Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids. Neurogastroenterol Motil 2020;32:e13753. [PMID: 31721398 DOI: 10.1111/nmo.13753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Reed RA, Knych HK, Barletta M, Sakai DM, Ruch MM, Smyth CA, Ryan CA. Pharmacokinetics and pharmacodynamics of hydromorphone after intravenous and intramuscular administration in horses. Vet Anaesth Analg 2020;47:210-8. [PMID: 31959534 DOI: 10.1016/j.vaa.2019.08.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Xie H, Zhou J, Du W, Zhang S, Huang R, Han Q, Guo Q. Impact of thoracic paravertebral block combined with general anesthesia on postoperative cognitive function and serum adiponectin levels in elderly patients undergoing lobectomy. Wideochir Inne Tech Maloinwazyjne 2019;14:538-44. [PMID: 31908700 DOI: 10.5114/wiitm.2019.84742] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Ozola-zālīte I, Frøkjær JB, Mark EB, Gudauskas T, Gudauskas L, Dedelaite M, Bieliuniene E, Ignatavicius P, Pukitis A, Drewes AM, Olesen SS. A Clinical Feasible Method for Computed Tomography-Based Assessment of Sarcopenia in Patients With Chronic Pancreatitis. Pancreas 2019;48:1354-9. [DOI: 10.1097/mpa.0000000000001439] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
33 Olesen AE, Grønlund D, Mark EB, Krogh K, Frøkjær JB, Drewes AM. Effects of Naloxegol on Gastrointestinal Transit and Colonic Fecal Volume in Healthy Participants Receiving Oxycodone. J Neurogastroenterol Motil 2019;25:602-10. [PMID: 31587551 DOI: 10.5056/jnm18079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
34 Goelen N, Hoon J, Morales JF, Varon C, Van Huffel S, Augustijns P, Mols R, Herbots M, Verbeke K, Vanuytsel T, Tack J, Janssen P. Codeine delays gastric emptying through inhibition of gastric motility as assessed with a novel diagnostic intragastric balloon catheter. Neurogastroenterology & Motility 2019;32. [DOI: 10.1111/nmo.13733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
35 Björklund P, Maleckas A, Lönroth H, Björnfot N, Thörn SE, Fändriks L. Roux Limb Motility in Gastric Bypass Patients with Chronic Abdominal Pain-Is There an Association to Prescribed Opioids? Obes Surg 2019;29:3860-7. [PMID: 31290106 DOI: 10.1007/s11695-019-04056-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Troberg K, Håkansson A, Dahlman D. Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment. J Addict 2019;2019:7942145. [PMID: 31139491 DOI: 10.1155/2019/7942145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
37 Lang-Illievich K, Bornemann-Cimenti H. Opioid-induced constipation: a narrative review of therapeutic options in clinical management. Korean J Pain 2019;32:69-78. [PMID: 31091505 DOI: 10.3344/kjp.2019.32.2.69] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Raffa RB, Taylor R, Pergolizzi JV. Treating opioid‐induced constipation in patients taking other medications: Avoiding CYP450 drug interactions. J Clin Pharm Ther 2019;44:361-71. [DOI: 10.1111/jcpt.12812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Rossi M, Casale G, Badiali D, Aielli F, Aloe Spiriti MA, Arcioni R, Bordin F, Ferrara M, Morelli Sbarra G, Corcione A, Marinangeli F, Marchetti P. Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board. Support Care Cancer 2019;27:4083-90. [PMID: 30778756 DOI: 10.1007/s00520-019-04688-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kuhlmann L, Olesen SS, Olesen AE, Arendt-Nielsen L, Drewes AM. Mechanism-based pain management in chronic pancreatitis - is it time for a paradigm shift? Expert Rev Clin Pharmacol 2019;12:249-58. [PMID: 30664364 DOI: 10.1080/17512433.2019.1571409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
41 Nishie K, Yamamoto S, Yamaga T, Horigome N, Hanaoka M. Peripherally acting μ‐opioid antagonist for the treatment of opioid‐induced constipation: Systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2018;34:818-29. [DOI: 10.1111/jgh.14586] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
42 Leppert W, Zajaczkowska R, Wordliczek J. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation. Expert Opin Pharmacother 2019;20:511-22. [PMID: 30625013 DOI: 10.1080/14656566.2018.1561863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
43 Mark EB, Bødker MB, Grønlund D, Østergaard LR, Frøkjaer JB, Drewes AM. MRI analysis of fecal volume and dryness: Validation study using an experimental oxycodone-induced constipation model. J Magn Reson Imaging 2019;50:733-45. [PMID: 30609164 DOI: 10.1002/jmri.26628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, Tack J. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J 2019;7:7-20. [PMID: 30788113 DOI: 10.1177/2050640618818305] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 15.8] [Reference Citation Analysis]
45 Reed R, Barletta M, Mitchell K, Hanafi A, Bullington A, Knych H, Quandt J, Ryan C, Giguère S. The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses. Vet Anaesth Analg 2019;46:395-404. [PMID: 30930095 DOI: 10.1016/j.vaa.2018.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
46 Grønlund D, Vase L, Knudsen SA, Christensen M, Drewes AM, Olesen AE. Comparison of subjective and objective measures of constipation – Employing a new method for categorizing gastrointestinal symptoms. Journal of Pharmacological and Toxicological Methods 2018;94:23-8. [DOI: 10.1016/j.vascn.2018.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Amirnovin R, Sanchez-pinto LN, Okuhara C, Lieu P, Koh JY, Rodgers JW, Nelson LP. Implementation of a Risk-Stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU: . Pediatric Critical Care Medicine 2018;19:1024-32. [DOI: 10.1097/pcc.0000000000001719] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
48 Song F, Ye C, Qi F, Zhang P, Wang X, Lü Y, Fernandez-Escobar A, Zheng C, Li L. Effect of perioperative infusion of Dexmedetomidine combined with Sufentanil on quality of postoperative analgesia in patients undergoing laparoscopic nephrectomy: a CONSORT-prospective, randomized, controlled trial. BMC Anesthesiol 2018;18:145. [PMID: 30342467 DOI: 10.1186/s12871-018-0608-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Bruin F, Hek K, Lieshout JV, Verduijn M, Langendijk P, Bouvy M, Teichert M. Laxative co-medication and changes in defecation patterns during opioid use. J Oncol Pharm Pract 2019;25:1613-21. [PMID: 30260269 DOI: 10.1177/1078155218801066] [Reference Citation Analysis]
50 Swezey T, Reeve BB, Hart TS, Floor MK, Dollar CM, Gillies AP, Tosi LL. Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community. Osteoporos Int 2019;30:507-11. [PMID: 30191258 DOI: 10.1007/s00198-018-4690-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Pannemans J, Corsetti M. Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders? Curr Opin Pharmacol 2018;43:53-8. [PMID: 30189347 DOI: 10.1016/j.coph.2018.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
52 Pannemans J, Vanuytsel T, Tack J. New developments in the treatment of opioid-induced gastrointestinal symptoms. United European Gastroenterol J 2018;6:1126-35. [PMID: 30288274 DOI: 10.1177/2050640618796748] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
53 Gálvez R, Maire C, Tovar I, Vargas P. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report. A A Pract 2018;11:22-4. [PMID: 29634552 DOI: 10.1213/XAA.0000000000000726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
54 Müller-Lissner S, Bassotti G, Coffin B, Drewes AM, Breivik H, Eisenberg E, Emmanuel A, Laroche F, Meissner W, Morlion B. Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Med 2017;18:1837-63. [PMID: 28034973 DOI: 10.1093/pm/pnw255] [Cited by in Crossref: 28] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
55 Bjorling DE, Wang ZY. Potential of Endocannabinoids to Control Bladder Pain. Front Syst Neurosci 2018;12:17. [PMID: 29867382 DOI: 10.3389/fnsys.2018.00017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
56 Piekielna-Ciesielska J, Mollica A, Pieretti S, Fichna J, Szymaszkiewicz A, Zielińska M, Kordek R, Janecka A. Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2. J Enzyme Inhib Med Chem 2018;33:560-6. [PMID: 29513114 DOI: 10.1080/14756366.2018.1441839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
57 Grønlund D, Poulsen JL, Krogh K, Brock C, Liao D, Gregersen H, Drewes AM, Olesen AE. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction. Eur J Pharm Sci 2018;117:187-92. [PMID: 29432808 DOI: 10.1016/j.ejps.2018.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
58 Sanchez-pinto LN, Nelson LP, Lieu P, Koh JY, Rodgers JW, Larson KA, Huson JM, Amirnovin R. Implementation of a risk-stratified opioid weaning protocol in a pediatric intensive care unit. Journal of Critical Care 2018;43:214-9. [DOI: 10.1016/j.jcrc.2017.08.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
59 Poulsen JL, Mark EB, Brock C, Frøkjær JB, Krogh K, Drewes AM. Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350. J Neurogastroenterol Motil 2018;24:119-27. [PMID: 29291613 DOI: 10.5056/jnm17058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
60 O'Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, McQuay HJ, Mikus G, Morlion BJ, Perez-Cajaraville J, Pogatzki-Zahn E, Varrassi G, Wells JC. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21:3-19. [PMID: 27991730 DOI: 10.1002/ejp.970] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 25.3] [Reference Citation Analysis]
61 Morlion BJ, Mueller-lissner SA, Vellucci R, Leppert W, Coffin BC, Dickerson SL, O'brien T. Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence. Pain Pract 2018;18:647-65. [DOI: 10.1111/papr.12646] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
62 Webster L, Diva U, Tummala R, Sostek M. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation. Pain Pract 2018;18:505-14. [PMID: 28898536 DOI: 10.1111/papr.12640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
63 Olesen SS, Frandsen LK, Poulsen JL, Vestergaard P, Rasmussen HH, Drewes AM. The prevalence of underweight is increased in chronic pancreatitis outpatients and associates with reduced life quality. Nutrition 2017;43-44:1-7. [DOI: 10.1016/j.nut.2017.06.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
64 Poulsen JL, Brock C, Grønlund D, Liao D, Gregersen H, Krogh K, Drewes AM. Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350. Dig Dis Sci 2017;62:3156-66. [PMID: 28986667 DOI: 10.1007/s10620-017-4784-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
65 Peng K, Zhang J, Chen WR, Liu HY, Ji FH. Ultrasound-guided Stellate Ganglion Block Improves Gastrointestinal Function After Thoracolumbar Spinal Surgery. Clin Ther 2017;39:2322-30. [PMID: 28974305 DOI: 10.1016/j.clinthera.2017.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
66 Koopmans-Klein G, Van Op den Bosch J, van Megen Y, Prenen H, Huygen F, Mancini I. Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment. Curr Med Res Opin 2017;33:2217-27. [PMID: 28805471 DOI: 10.1080/03007995.2017.1367276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
67 Chokhavatia S, John ES, Bridgeman MB, Dixit D. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs Aging 2016;33:557-74. [PMID: 27417446 DOI: 10.1007/s40266-016-0381-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
68 Jiang L, Beattie DT, Jacobsen JR, Kintz S, Obedencio GP, Saito D, Stergiades I, Vickery RG, Long DD. Discovery of N -substituted- endo -3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2017;27:2926-30. [DOI: 10.1016/j.bmcl.2017.04.092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
69 Kokki M, Kuronen M, Naaranlahti T, Nyyssönen T, Pikkarainen I, Savolainen S, Kokki H. Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment. Adv Ther 2017;34:236-51. [PMID: 27921252 DOI: 10.1007/s12325-016-0456-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
70 Olesen SS, Graversen C, Bouwense SA, Wilder-Smith OH, van Goor H, Drewes AM. Is Timing of Medical Therapy Related to Outcome in Painful Chronic Pancreatitis? Pancreas 2016;45:381-7. [PMID: 26474430 DOI: 10.1097/MPA.0000000000000475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
71 Chen NY, Nguyen E, Schrager SM, Russell CJ. Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation. Hosp Pediatr 2016;6:677-83. [PMID: 27803072 DOI: 10.1542/hpeds.2016-0014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
72 Weber HC. Opioid-induced constipation in chronic noncancer pain. Curr Opin Endocrinol Diabetes Obes 2016;23:11-7. [PMID: 26702846 DOI: 10.1097/MED.0000000000000220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
73 Williams DA, Zheng Y, David BG, Yuan Y, Zaidi SA, Stevens DL, Scoggins KL, Selley DE, Dewey WL, Akbarali HI, Zhang Y. 6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand. ACS Chem Neurosci 2016;7:1120-9. [PMID: 27269866 DOI: 10.1021/acschemneuro.6b00075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
74 Lawson R, King F, Marsh K, Altincatal A, Cimen A. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility. Adv Ther 2016;33:1331-46. [PMID: 27342744 DOI: 10.1007/s12325-016-0365-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Yoshimoto T, Tomiyasu S, Saeki T, Tamaki T, Hashizume T, Murakami M, Matoba M; Symptom Control Research Group (SCORE-G). How Do Hospital Palliative Care Teams Use the WHO Guidelines to Manage Unrelieved Cancer Pain? A 1-Year, Multicenter Audit in Japan. Am J Hosp Palliat Care 2017;34:92-9. [DOI: 10.1177/1049909115608810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Olesen SS, Poulsen JL, Broberg MC, Madzak A, Drewes AM. Opioid treatment and hypoalbuminemia are associated with increased hospitalisation rates in chronic pancreatitis outpatients. Pancreatology 2016;16:807-13. [PMID: 27320721 DOI: 10.1016/j.pan.2016.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
77 Olesen AE, Farmer AD, Olesen SS, Aziz Q, Drewes AM. Management of chronic visceral pain. Pain Manag 2016;6:469-86. [PMID: 27256577 DOI: 10.2217/pmt-2015-0011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
78 Leppert W, Woron J. The role of naloxegol in the management of opioid-induced bowel dysfunction. Therap Adv Gastroenterol 2016;9:736-46. [PMID: 27582887 DOI: 10.1177/1756283X16648869] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
79 Nilsson M, Poulsen JL, Brock C, Sandberg TH, Gram M, Frøkjær JB, Krogh K, Drewes AM. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI: . European Journal of Gastroenterology & Hepatology 2016;28:514-24. [DOI: 10.1097/meg.0000000000000574] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
80 Poulsen JL, Nilsson M, Brock C, Sandberg TH, Krogh K, Drewes AM. The Impact of Opioid Treatment on Regional Gastrointestinal Transit. J Neurogastroenterol Motil 2016;22:282-91. [PMID: 26811503 DOI: 10.5056/jnm15175] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
81 Drewes AM, Munkholm P, Simrén M, Breivik H, Kongsgaard UE, Hatlebakk JG, Agreus L, Friedrichsen M, Christrup LL. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction–Recommendations of the Nordic Working Group. Scandinavian Journal of Pain 2016;11:111-22. [DOI: 10.1016/j.sjpain.2015.12.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
82 Siemens W, Becker G. Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes. Ther Clin Risk Manag 2016;12:401-12. [PMID: 27042082 DOI: 10.2147/TCRM.S80749] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
83 Rumman A, Gallinger ZR, Liu LWC. Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Review of Quality of Life in Cancer Care 2016;1:25-35. [DOI: 10.1080/23809000.2016.1131595] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
84 Garnock-Jones KP. Naloxegol: a review of its use in patients with opioid-induced constipation. Drugs 2015;75:419-25. [PMID: 25666542 DOI: 10.1007/s40265-015-0357-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
85 Nilsson M, Brock C, Lykke Poulsen J, Bindslev N, Berner Hansen M, Louring Christrup L, Drewes A. Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon. Scandinavian Journal of Gastroenterology 2016;51:538-47. [DOI: 10.3109/00365521.2015.1116108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Poulsen JL, Brock C, Olesen AE, Nilsson M, Drewes AM. Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therap Adv Gastroenterol 2015;8:360-72. [PMID: 26557892 DOI: 10.1177/1756283X15589526] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
87 Tack J, Lappalainen J, Diva U, Tummala R, Sostek M. Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate response. United European Gastroenterol J 2015;3:471-80. [PMID: 26535126 DOI: 10.1177/2050640615604543] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
88 Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group. Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2015;14:1161-70. [PMID: 26494524 DOI: 10.1016/S1474-4422(15)00243-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 10.4] [Reference Citation Analysis]
89 Bian X, Zhou R, Yang Y, Li P, Hang Y, Hu Y, Yang L, Wen D. Divergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats. Int J Med Sci 2015;12:848-52. [PMID: 26640403 DOI: 10.7150/ijms.12616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
90 Eldon MA, Kugler AR, Medve RA, Bui K, Butler K, Sostek M. Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending-dose study. Clin Pharmacol Drug Dev 2015;4:434-41. [PMID: 27137715 DOI: 10.1002/cpdd.206] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
91 Bujedo BM. Treatment of failed back surgery syndrome in a forty-three-year-old man with high-dose oxycodone/naloxone. Anesth Pain Med 2015;5:e21009. [PMID: 25893186 DOI: 10.5812/aapm.21009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
92 Leppert W. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Des Devel Ther 2015;9:2215-31. [PMID: 25931815 DOI: 10.2147/DDDT.S32684] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
93 Brokjaer A, Olesen AE, Christrup LL, Dahan A, Drewes AM. The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants. Neurogastroenterol Motil 2015;27:693-704. [DOI: 10.1111/nmo.12545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
94 Siemens W, Gaertner J, Becker G. Advances in pharmacotherapy for opioid-induced constipation - a systematic review. Expert Opin Pharmacother 2015;16:515-32. [PMID: 25539282 DOI: 10.1517/14656566.2015.995625] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
95 Jitpakdee T, Mandee S. Strategies for preventing side effects of systemic opioid in postoperative pediatric patients. Paediatr Anaesth 2014;24:561-8. [PMID: 24809837 DOI: 10.1111/pan.12420] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
96 Corsetti M, Tack J. Naloxegol , a new drug for the treatment of opioid-induced constipation. Expert Opin Pharmacother 2015;16:399-406. [PMID: 25496063 DOI: 10.1517/14656566.2015.991306] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
97 Stienen MN, Smoll NR, Hildebrandt G, Schaller K, Tessitore E, Gautschi OP. Constipation after thoraco-lumbar fusion surgery. Clinical Neurology and Neurosurgery 2014;126:137-42. [DOI: 10.1016/j.clineuro.2014.08.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
98 Blagden M, Hafer J, Duerr H, Hopp M, Bosse B. Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials. Neurogastroenterol Motil 2014;26:1792-801. [PMID: 25346155 DOI: 10.1111/nmo.12463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
99 Gibson CM, Pass SE. Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit. Journal of Critical Care 2014;29:803-7. [DOI: 10.1016/j.jcrc.2014.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
100 Blackshaw LA, Bordin DS, Brock C, Brokjaer A, Drewes AM, Farmer AD, Krarup AL, Lottrup C, Masharova AA, Moawad FJ, Olesen AE. Pharmacologic treatments for esophageal disorders: Pharmacologic treatments for esophageal disorders. Ann N Y Acad Sci 2014;1325:23-39. [DOI: 10.1111/nyas.12520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
101 Poulsen JL, Brock C, Olesen AE, Nilsson M, Drewes AM. Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction. Clin Exp Gastroenterol 2014;7:345-58. [PMID: 25278772 DOI: 10.2147/CEG.S52097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
102 Tack J, Corsetti M. Naloxegol for the treatment of opioid-induced constipation. Expert Rev Gastroenterol Hepatol 2014;8:855-61. [PMID: 25220391 DOI: 10.1586/17474124.2014.939629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
103 Boules M, Shimizu H, Zelisko A, El-Hayek K, Rizk MK, Kroh M. Pre-operative opioid analgesia reduces clinical success of laparoscopic gastric electrical stimulation placement in patients with gastroparesis. Surg Endosc 2015;29:805-9. [PMID: 25115865 DOI: 10.1007/s00464-014-3754-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
104 Shi Y, Zhang Y, Zhao F, Ruan H, Huang H, Luo L, Li L. Acetylcholine serves as a derepressor in Loperamide-induced Opioid-Induced Bowel Dysfunction (OIBD) in zebrafish. Sci Rep 2014;4:5602. [PMID: 24998697 DOI: 10.1038/srep05602] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
105 Leppert W. New treatment possibilities for opioid-induced bowel dysfunction. Pain 2013;154:1491-2. [PMID: 23953125 DOI: 10.1016/j.pain.2013.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
106 Petrov MS, Windsor JA. Nutritional management of acute pancreatitis: the concept of 'gut rousing'. Curr Opin Clin Nutr Metab Care. 2013;16:557-563. [PMID: 23799325 DOI: 10.1097/mco.0b013e3283638ed1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
107 Rauck RL. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone. Drugs 2013;73:1297-306. [PMID: 23881667 DOI: 10.1007/s40265-013-0084-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
108 Burness CB, Keating GM. Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation. Drugs 2014;74:353-75. [DOI: 10.1007/s40265-014-0177-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
109 Nilsson M, Piasco A, Nissen T, Graversen C, Gazerani P, Lucas M, Dahan A, Drewes A, Brock C. Reproducibility of psychophysics and electroencephalography during offset analgesia: Reproducibility of offset analgesia. EJP 2014;18:824-34. [DOI: 10.1002/j.1532-2149.2013.00424.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
110 Poulsen JL, Olesen SS, Malver LP, Frøkjær JB, Drewes AM. Pain and chronic pancreatitis: A complex interplay of multiple mechanisms. World J Gastroenterol 2013; 19(42): 7282-7291 [PMID: 24259959 DOI: 10.3748/wjg.v19.i42.7282] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
111 Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307 [PMID: 24259961 DOI: 10.3748/wjg.v19.i42.7302] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
112 Olesen SS, Juel J, Graversen C, Kolesnikov Y, Wilder-Smith OH, Drewes AM. Pharmacological pain management in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7292-7301 [PMID: 24259960 DOI: 10.3748/wjg.v19.i42.7292] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
113 Sellers RS, Morton D. The colon: from banal to brilliant. Toxicol Pathol 2014;42:67-81. [PMID: 24129758 DOI: 10.1177/0192623313505930] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
114 Gravante G, Yahia S. Medical influences, surgical outcomes: Role of common medications on the risk of perforation from untreated diverticular disease. World J Gastroenterol 2013; 19(36): 5947-5952 [PMID: 24106394 DOI: 10.3748/wjg.v19.i36.5947] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
115 Salman N, Durukan AB, Gurbuz HA, Yamalı H, Guler L, Ucar HI, Yorgancioglu C. Comparison of effects of epidural bupivacaine and intravenous meperidine analgesia on patient recovery following elective abdominal aortic surgery. Med Sci Monit 2013;19:347-52. [PMID: 23666275 DOI: 10.12659/MSM.889005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
116 Leppert W. The place of oxycodone/naloxone in chronic pain management. Contemp Oncol (Pozn) 2013;17:128-33. [PMID: 23788978 DOI: 10.5114/wo.2013.34614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
117 Tsuruda PR, Vickery RG, Long DD, Armstrong SR, Beattie DT. The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 2013;386:479-91. [DOI: 10.1007/s00210-013-0850-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
118 Anselmi L, Jaramillo I, Palacios M, Huynh J, Sternini C. Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanyl. J Neurosci Res 2013;91:854-60. [PMID: 23553842 DOI: 10.1002/jnr.23214] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
119 Davis M, Goforth HW, Gamier P. Oxycodone combined with opioid receptor antagonists: efficacy and safety. Expert Opin Drug Saf 2013;12:389-402. [PMID: 23534906 DOI: 10.1517/14740338.2013.783564] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
120 Adis Medical Writers. Patients receiving opioids for pain usually require additional pharmacological treatment for opioid-induced constipation. Drugs Ther Perspect 2013;29:117-21. [DOI: 10.1007/s40267-013-0019-y] [Reference Citation Analysis]
121 Sobczak M, Sałaga M, Storr MA, Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol 2014;49:24-45. [PMID: 23397116 DOI: 10.1007/s00535-013-0753-x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 11.8] [Reference Citation Analysis]
122 van Zanten AR. Nutrition barriers in abdominal aortic surgery: a multimodal approach for gastrointestinal dysfunction. JPEN J Parenter Enteral Nutr 2013;37:172-7. [PMID: 23100540 DOI: 10.1177/0148607112464499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]